MedPath

Randomized controlled study on Huotan Tongluo Decoction in the treatment of refractory Mycoplasma pneumonia in childre

Phase 1
Conditions
Refractory Mycoplasma pneumonia in children
Registration Number
ITMCTR2000003671
Lead Sponsor
onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1) Those who meet the diagnostic criteria of Western medicine and traditional Chinese medicine and syndrome differentiation criteria of refractory Mycoplasma pneumonia in children;
2) The age ranged from 3 to 14 years old;
3) The parents of the subjects signed the informed consent form and were able to cooperate.

Exclusion Criteria

1) Patients with other immune diseases and / or using immunomodulators;
2) Patients with heart failure, respiratory failure, hypoxic encephalopathy and other serious complications;
3) Patients with severe liver and kidney disease, cardiovascular disease, endocrine disease, blood system disease, nervous system disease.
4) Allergy to the test drug;
5) Patients who have participated in or are participating in clinical trials of other drugs in recent three months;
6) According to the doctor's judgment, it is easy to lose the follow-up.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Symptom;lung CT;VEGF;D-Dimer;TNF-a;Pulmonary function;IL6;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath